2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study is being done in an attempt to improve the remission rate and the survival time
for subjects with high-risk myeloma. It is hoped that by giving higher doses of commonly used
chemotherapy drugs and by giving courses closer together (before the myeloma comes back or
gets worse), subjects in this study will have better outcomes.